Reported 4 months ago
Industry executives doubt that higher U.S. tariffs on Chinese medical imports, including gloves, syringes, and face masks, will make American producers more competitive, as other low-cost suppliers are likely to step in to fill the gap. Washington's tariff hikes are part of an effort to stimulate domestic production and combat supply shortages experienced during the COVID-19 pandemic. However, industry insiders suggest that Chinese firms may reroute shipments through other countries like Malaysia, potentially undermining the impact of the tariffs. U.S. producers argue that they need immediate support rather than tariffs that are set to take effect in the future. The U.S. Trade Representative's office is seeking public input on the proposed tariff increases, while some U.S. producers believe that the focus should be on enforcing "Buy American" rules and securing government contracts.
Source: YAHOO